Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 53

1.

Civil War pharmacy: historical parallels and implications for disaster preparedness.

Ford H, Tackett RL.

Pharm Hist (Lond). 2013 Jun;43(2):26-8. No abstract available.

PMID:
24624707
2.

Obesity affects short-term folate pharmacokinetics in women of childbearing age.

da Silva VR, Hausman DB, Kauwell GP, Sokolow A, Tackett RL, Rathbun SL, Bailey LB.

Int J Obes (Lond). 2013 Dec;37(12):1608-10. doi: 10.1038/ijo.2013.41. Epub 2013 Apr 9.

PMID:
23567925
3.

Effect of St. John's wort on free radical production.

Hunt EJ, Lester CE, Lester EA, Tackett RL.

Life Sci. 2001 Jun 1;69(2):181-90.

PMID:
11441908
4.

Determination of arginine and methylated arginines in human plasma by liquid chromatography-tandem mass spectrometry.

Vishwanathan K, Tackett RL, Stewart JT, Bartlett MG.

J Chromatogr B Biomed Sci Appl. 2000 Oct 1;748(1):157-66.

PMID:
11092595
5.

Distribution of endothelin receptors in saphenous veins of African Americans: implications of racial differences.

Ergul A, Tackett RL, Puett D.

J Cardiovasc Pharmacol. 1999 Sep;34(3):327-32.

PMID:
10470988
6.

St. John's wort: a new alternative for depression?

Josey ES, Tackett RL.

Int J Clin Pharmacol Ther. 1999 Mar;37(3):111-9. Review.

PMID:
10190758
7.

Palmar digital vessel relaxation in healthy horses and in horses given carbohydrate.

Schneider DA, Parks AH, Eades SC, Tackett RL.

Am J Vet Res. 1999 Feb;60(2):233-9.

PMID:
10048558
9.

Gender differences in the expression of endothelin receptors in human saphenous veins in vitro.

Ergul A, Shoemaker K, Puett D, Tackett RL.

J Pharmacol Exp Ther. 1998 May;285(2):511-7.

11.

Indicators of postoperative pain in cats and correlation with clinical criteria.

Smith JD, Allen SW, Quandt JE, Tackett RL.

Am J Vet Res. 1996 Nov;57(11):1674-8.

PMID:
8915451
12.
13.

Insulin attenuates alpha-adrenergic aortic contraction in normotensive but not borderline hypertensive rats.

Winecoff AP, Tackett RL, Fuchs LC.

Clin Exp Hypertens. 1995 Jul;17(5):787-801.

PMID:
7655448
14.

Nonsuperoxide lucigenin-enhanced chemiluminescence from phospholipids and human saphenous veins.

Barber DA, Do NH, Tackett RL, Capomacchia AC.

Free Radic Biol Med. 1995 Mar;18(3):565-9.

PMID:
9101248
15.

Physiologically based pharmacokinetic model useful in prediction of the influence of species, dose, and exposure route on perchloroethylene pharmacokinetics.

Dallas CE, Chen XM, Muralidhara S, Varkonyi P, Tackett RL, Bruckner JV.

J Toxicol Environ Health. 1995 Mar;44(3):301-17.

PMID:
7897693
16.

Angiotensin II receptors and potassium channels: targets for new cardiovascular drugs.

Barber DA, Barber CH, Bivins CL, Tackett RL.

J Pract Nurs. 1995 Mar;45(1):32-9; quiz 40-2. No abstract available.

PMID:
7714840
17.

The use of methylene blue as an extravascular surgical marker impairs vascular responses of human saphenous veins.

Barber DA, Rubin JW, Zumbro GL, Tackett RL.

J Thorac Cardiovasc Surg. 1995 Jan;109(1):21-9.

18.

Opioidergic receptors in the arcuate nucleus are not involved in the cardiovascular effects of clonidine.

Barber DA, Tackett RL.

Pharmacol Biochem Behav. 1994 Nov;49(3):579-82.

PMID:
7862711
19.

Use of tissue disposition data from rats and dogs to determine species differences in input parameters for a physiological model for perchloroethylene.

Dallas CE, Chen XM, Muralidhara S, Varkonyi P, Tackett RL, Bruckner JV.

Environ Res. 1994 Oct;67(1):54-67.

PMID:
7925194
20.

Copper deficient rat heart can compensate for doxorubicin-induced oxidant stress.

Fischer JG, Tackett RL, Howerth EW, Johnson MA.

Biol Trace Elem Res. 1993 May-Jun;37(2-3):233-51.

PMID:
7688536
21.

Copper and selenium deficiencies do not enhance the cardiotoxicity in rats due to chronic doxorubicin treatment.

Fischer JG, Tackett RL, Howerth EW, Johnson MA.

J Nutr. 1992 Nov;122(11):2128-37.

PMID:
1432253
22.

Hemodynamic effects of centrally administered, norcocaine in the rat.

Barber DA, Tackett RL.

Life Sci. 1992;51(16):1269-76.

PMID:
1406048
23.

The effect of copper deficiency on adriamycin toxicity.

Fischer J, Johnson MA, Tackett RL.

Toxicol Lett. 1991 Jul;57(2):147-58.

PMID:
1649500
24.

Differential routes of cocaine administration indicate a peripheral cardiotoxic action.

Jones LF, Tackett RL.

Pharmacol Biochem Behav. 1991 Mar;38(3):601-3.

PMID:
2068197
25.
26.

In vitro responses of equine digital vessels to dopamine and fenoldopam.

Baxter GM, Moore JN, Tackett RL.

Equine Vet J. 1991 Jan;23(1):48-52.

PMID:
1673099
28.
29.

Central mechanisms of action involved in cocaine-induced tachycardia.

Jones LF, Tackett RL.

Life Sci. 1990;46(10):723-8.

PMID:
2314194
30.

Cardiovascular function and serum catecholamine concentrations after anesthesia and surgery in the dog.

Rawlings CA, Tackett RL, Bjorling DE, Arnold TH Jr.

Vet Surg. 1989 Jul-Aug;18(4):255-60.

PMID:
2773289
31.

Catecholaminergic and opioidergic mechanisms involved in the hypotensive response of pindolol.

Jones LF, Tackett RL.

Eur J Pharmacol. 1989 Jun 8;165(1):123-8.

PMID:
2767128
32.

Relationship of plasma clonidine to growth hormone concentrations in children and adolescents.

Hoffman WH, DiPiro JT, Tackett RL, Arrendale RF, Hahn DA.

J Clin Pharmacol. 1989 Jun;29(6):538-42.

PMID:
2754022
33.

Reactivity of equine palmar digital arteries and veins to vasodilating agents.

Baxter GM, Tackett RL, Moore JN.

Vet Surg. 1989 May-Jun;18(3):221-6.

PMID:
2773284
34.

In vitro reactivity of digital arteries and veins to vasoconstrictive mediators in healthy horses and in horses with early laminitis.

Baxter GM, Laskey RE, Tackett RL, Moore JN, Allen D.

Am J Vet Res. 1989 Apr;50(4):508-17.

PMID:
2712417
35.

Naloxone pretreatment blocks the hypotensive effects of atenolol in SHR and WKY rats.

Laskey RE, Jones LF, Tackett RL.

Pharmacology. 1989;39(2):109-14.

PMID:
2798550
36.
37.

Interaction of propranolol with central serotonergic neurons.

Jones LF, Tackett RL.

Life Sci. 1988;43(26):2249-55.

PMID:
2463453
38.

Naloxone inhibits the centrally-mediated hypotensive actions of BHT-933 (azepexole).

Tackett RL, Laskey R.

Life Sci. 1987 Oct 26;41(17):2063-7.

PMID:
2823037
39.

Increases in CSF norepinephrine associated with the onset of digoxin-induced arrhythmias.

Plunkett LM, Tackett RL.

Eur J Pharmacol. 1987 Apr 7;136(1):119-22.

PMID:
3595711
40.

Pharmacokinetics of tiazofurin in dogs.

Obeng EK, Vallner JJ, Cadwallader DE, Tackett RL.

Biopharm Drug Dispos. 1987 Mar-Apr;8(2):125-32.

PMID:
3593893
41.

Central dopamine receptors and their role in digoxin-induced cardiotoxicity in the dog.

Plunkett LM, Tackett RL.

J Pharm Pharmacol. 1987 Jan;39(1):29-34.

PMID:
2880980
42.
43.

Age-related changes in the pharmacodynamics of verapamil.

Arnold TH, Vallner JJ, Tackett RL.

Am Heart J. 1985 Nov;110(5):981-5.

PMID:
4061274
44.

Pharmacodynamics of acute intranasal administration of verapamil: comparison with i.v. and oral administration.

Arnold TH, Tackett RL, Vallner JJ.

Biopharm Drug Dispos. 1985 Oct-Dec;6(4):447-54.

PMID:
4084670
45.

Site and mechanism of the centrally mediated hypotensive action of propranolol.

Tackett RL, Webb JG, Privitera PJ.

J Pharmacol Exp Ther. 1985 Oct;235(1):66-70.

PMID:
4045728
46.

The effects of central beta-receptor antagonism on digoxin cardiotoxicity.

Plunkett LM, Tackett RL.

Res Commun Chem Pathol Pharmacol. 1985 May;48(2):209-20.

PMID:
2862669
47.

Prazosin alters free and total plasma digoxin levels in dogs.

Plunkett LM, Gokhale RD, Vallner JJ, Tackett RL.

Am Heart J. 1985 Apr;109(4):847-51.

PMID:
3984839
48.

Altered vascular reactivity in the rabbit during hypercholesterolemia.

Heric E, Tackett RL.

Pharmacology. 1985;31(2):72-81.

PMID:
4023047
49.

Effects of magnesium on the action of vasodilatory agents.

Arnold TH, Tackett RL.

Pharmacology. 1985;31(4):218-24.

PMID:
3933021
50.

Central alpha receptors and their role in digoxin cardiotoxicity.

Plunkett LM, Tackett RL.

J Pharmacol Exp Ther. 1983 Dec;227(3):683-6.

PMID:
6317844

Supplemental Content

Loading ...
Support Center